The introduction of nicotinamide being a nicotine substitution in e-cigarette and smokeless solutions represents an important regulatory obstacle for that FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is understood to work as a sedative at superior dosages6. The promises made by Nicotine River, ECBlend, together with other